Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Politics

CDC eyes narrower COVID-19 vaccine guidance ahead of 2025–2026 season

by April 15, 2025
April 15, 2025

The Centers for Disease Control and Prevention’s (CDC’s) vaccine advisory committee will meet on Tuesday for a two-day session to lay out new recommendations, including a proposal to scale back current COVID-19 vaccine guidelines.

Dr. Lakshmi Panagiotakopoulos of the CDC is expected to present guidance on COVID-19 vaccine use for 2025–2026 and suggest the department adopt a ‘narrow’ recommendation for it, ‘and only maintain this series for certain populations within these groups who we determine should be vaccinated.’

When polled on April 3, a majority of advisors – 76% – expressed support for a risk-based, rather than universal, COVID-19 vaccination recommendation for the 2025–2026 schedule, up 10% higher from February polling.

The 70-page presentation outlines three possible policy options for COVID-19 vaccines, including a shift away from recommending annual shots for everyone over 6 months old.

Currently, annual COVID-19 shots are recommended for ages 6 months and older. One proposed policy option would continue the current universal policy, while another would recommend vaccines only for people at higher risk of severe illness, such as older adults, those with underlying health conditions, pregnant women and healthcare workers. 

A third option would blend the two, keeping universal recommendations for people 65 and older but limiting shots for younger groups to those at higher risk.

‘When initially presented with 2025–2026 COVID-19 vaccine policy options in November 2024, the Work Group appreciated pros and cons of both risk-based and universal vaccine recommendations,’ Panagiotakopoulos wrote. ‘At that time, there was not yet a consensus on what the recommendation for the 2025–2026 COVID-19 vaccine should be. The Work Group requested additional information to help inform the decision-making process on risk-factors for severe COVID-19, transmission and immunity, vaccine implementation and access, and cost-effectiveness.’

The presentation will also propose how to define ‘increased risk,’ looking at both health factors and increased exposure, like living in long-term care facilities or working in high-contact jobs.

The two-day meeting of the Advisory Committee on Immunization Practices will examine information for members to vote on as official recommendations, which will then be passed on to the CDC for consideration in June.

The end of the presentation will include discussion questions about the pros and cons of a universal vs. risk-based COVID-19 vaccine recommendation for 2025 to 2026. Key discussion points include whether any groups should be excluded from vaccination, what data is still needed to guide decisions, and whether a risk-based approach makes sense if most people are already considered ‘at risk.’

According to the CDC, the vaccine committee’s agenda will also include a session about the measles outbreak and an update ‘on literature related to reduced number of doses for HPV vaccine.’

Members of the committee will vote on Wednesday on recommendations for the Meningococcal Vaccines, Meningococcal Vaccines VFC, RSV Adult and the Chikungunya Vaccines.

The meeting comes as Health and Human Services Secretary Robert F. Kennedy Jr. is overseeing a major reorganization of the CDC. Plans include transferring non-infectious disease-related divisions to the Administration for a Healthy America to focus on chronic disease management. This move follows significant downsizing under President Donald Trump’s directive, which has already reduced the CDC workforce by roughly 4,000 people.

This post appeared first on FOX NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Top Republican warns families of ‘largest tax hike in history’ next year if Trump budget fails
next post
Bill Maher’s Embrace of Civil Discourse Is No Laughing Matter

You may also like

‘Nothing but hypocrisy’: House GOP doubtful DOJ will...

June 13, 2024

Putin hit man seen as Russia’s big prize...

August 1, 2024

Medical Examiner-Coroner Claims Fully Vaccinated Body Builder Who...

October 30, 2022

Rubio to introduce Senate resolution canceling visas for...

October 18, 2023

Biden Follows in Obama’s Footsteps, Trades Pot-Smoking B-Ball...

December 8, 2022

China sanctions former Republican Rep Mike Gallagher after...

May 21, 2024

Republicans blast departing GOP lawmakers as razor-thin majority...

March 27, 2024

Moscow returns body of Ukrainian journalist killed in...

April 30, 2025

‘Squad’ Dems to rally for Cori Bush as...

August 5, 2024

Harris ripped by Trump campaign after Beyoncé doesn’t...

October 26, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Netflix accused of copying show idea by ‘Queen of bling’ Celia Sawyer

      May 30, 2025
    • Reform UK becomes first British political party to accept Bitcoin donations, says Farage

      May 30, 2025
    • UK business confidence jumps to nine-month high as trade tensions ease

      May 30, 2025
    • Bailey urges Starmer to deepen EU ties to soften Brexit blow and counter Trump tariffs

      May 30, 2025
    • Royal family’s wine merchant to open first US store in Washington

      May 30, 2025
    • Starlink set to expand UK footprint as Ofcom greenlights new spectrum licences

      May 30, 2025

    Categories

    • Business (8,104)
    • Investing (1,996)
    • Politics (15,434)
    • Stocks (3,115)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved